Profile for Japan Patent: 4928941
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 4928941
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,301,050 | Aug 2, 2026 | Gilead Sciences Inc | LIVDELZI | seladelpar lysine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
